




• The global Encorafenib market size was valued at US$ 456.3 million in 2024 and is projected to reach US$ 782.9 million by 2030, at a CAGR of 9.4% during the forecast period 20242030.

• United States Encorafenib market size was valued at US$ 213.7 million in 2024 and is projected to reach US$ 358.4 million by 2030, at a CAGR of 9.0% during the forecast period 2024-2030.


